Self-sampling identifies twice as many women at risk of cervical cancer

February 15, 2018, Uppsala University

Using self-sampling followed by HPV testing, more than twice as many women at risk of developing cervical cancer could be identified and offered preventive treatment. This is shown by researchers at Uppsala University in the first randomised study in the world comparing two ways of identifying cervical cancer, published today in the British Journal of Cancer.

Cervical cancer screening has previously been based on cell sampling and cytology. This method initially reduced the number of cases of in Sweden substantially, but additional effects have been difficulty to achieve. This is due to the limited sensitivity of the method, and the fact that not all attend screening.

In the new study, researchers have compared today's screening based on cytology and sampling by a , with the woman taking a self-sample and submitting it for analysis of , HPV, which is the cause of cervical cancer.

The study is based on 36,390 women between the ages of 30 and 49 who participated in the organised screening in Uppsala County, 2013-2015. These were divided into two groups: one group performed self-sampling for an HPV test, while the other group had a midwife take a cell sample for cytological analysis. Women who were HPV positive repeated the self-sampling after 4 months and those who were HPV positive in both of their tests were called in for gynaecological examination. During 18 months of follow-up, the number of women with severe cell changes was recorded for both groups.

The results show that self-sampling was received very positively. Of the women who were offered self-sampling, 47% opted to participate, compared with 39% among those who were offered regular cell sampling. Among the women who did self-sampling for HPV testing, more than twice as many with cell changes were found than among those who had a cytology analysis. Also, the time until diagnosis was shorter for those who did self-sampling.

This is the first randomised study in the world that compares these two ways of identifying cervical cancer. By using self-sampling followed by HPV testing, more than twice as many women at risk of cervical cancer could be identified and offered . Screening based on self-sampling also makes it possible to reach women who have previously chosen not to participate and have a sample taken by a midwife.

Calculations of the health-economic consequences of self-sampling and HPV testing show that the total cost of cervical screening could be halved, while still being twice as effective as current the method. Few changes in healthcare can simultaneously double the effectiveness and halve the cost. Screening based on self-sampling also makes it possible to reach women who have chosen not to participate in the cell sampling and take a sample in midwife.

Explore further: Improving cervical cancer screening rates for transgender men

More information: Inger Gustavsson et al, Randomised study shows that repeated self-sampling and HPV test has more than two-fold higher detection rate of women with CIN2+ histology than Pap smear cytology, British Journal of Cancer (2018). DOI: 10.1038/bjc.2017.485

Related Stories

Improving cervical cancer screening rates for transgender men

September 8, 2017
A new study indicates that alternative options for cervical cancer screening, including self-sampling for human papilloma virus (HPV) testing, could improve the screening rate among transgender men. More than half of the ...

Facts women and men should know about cervical cancer

January 22, 2018
January is Cervical Cancer Awareness month and the message from the Centers from Disease Control and Prevention is that "no woman should die from cervical cancer."

Screening for cervical abnormalities in women offered HPV vaccination

September 19, 2017
Human papillomavirus (HPV) testing detects a higher number of precancerous cervical lesions than cytology-based Pap smears in a female population including a proportion offered HPV vaccination, according to a new study published ...

ACOG: New recommendations for cervical cancer screening

December 23, 2015
(HealthDay)—In a practice bulletin published in the January issue of Obstetrics & Gynecology, new recommendations are presented for cervical cancer screening and prevention.

Urine HPV test could offer non-invasive alternative to conventional smear, improve screening uptake

September 16, 2014
Human papillomavirus (HPV) is one of the most common sexually transmitted infections. Up to 80% of sexually active women are infected at some point in their lives and infection with specific "high risk" strains of HPV has ...

Previous screening results important for decision about smear tests after age 60

October 25, 2017
Being screened again after the age of 60 reduces the risk of cervical cancer in women who have previously had abnormal smear tests and in women who did not have smear tests in their 50s, researchers at Karolinska Institutet ...

Recommended for you

Two ways cancer resists treatment are actually connected, with one activating the other

December 18, 2018
Drugs that target BRAF and MEK in cancer have shown promise in treating a subset of melanoma that carries a mutation in the BRAF gene, but drug resistance usually emerges, reversing the benefit of these drugs and limiting ...

HPV discovery raises hope for new cervical cancer treatments

December 18, 2018
Researchers at the University of Virginia School of Medicine have made a discovery about human papillomavirus (HPV) that could lead to new treatments for cervical cancer and other cancers caused by the virus.

Vaccine, checkpoint drugs combination shows promise for pancreatic cancers

December 18, 2018
Researchers at the Johns Hopkins Kimmel Cancer Center discovered a combination of a cancer vaccine with two checkpoint drugs reduced pancreatic cancer tumors in mice, demonstrating a possible pathway for treatment of people ...

Researchers identify ways breast cancer avoids immune system detection

December 18, 2018
Recent breakthroughs in immunotherapy are making a huge difference in treating some forms of cancer, especially metastatic cancer. But breast cancer has proven a tricky foe for this new therapy, and an interdisciplinary team ...

Metal chemotherapy drugs boost the impact of immunotherapy in cancer

December 18, 2018
Due to their powerful tumour-killing effect, metal-based chemotherapies are frequently used in cancer treatment. However, it was hitherto assumed that they damaged the immune system, because of their cytotoxic (cell-damaging) ...

10-year follow-up after negative colonoscopies linked to lower colorectal cancer risk

December 17, 2018
Ten years after a negative colonoscopy, Kaiser Permanente members had 46 percent lower risk of being diagnosed with and were 88 percent less likely to die from colorectal cancer compared with those who did not undergo colorectal ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.